Sector dividends Cardiol Therapeutics Inc.
Stocks
CRDL
CA14161Y2006
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.630 CAD | -4.12% |
|
-10.44% | +24.43% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -3.4x | 9.26x | - | -6.72x | -4.93x | 133M | |
| 0.96% | 1.09% | 33.57x | 4.49x | 6.03x | 17.92x | 25.11x | 48.95B | |
| -.--% | -.--% | 32.11x | 5.91x | 3.13x | 13.52x | 20.7x | 40.75B | |
| -.--% | -.--% | -22.58x | 17.7x | 337.47x | -20.61x | -20.54x | 38.46B | |
| -.--% | -.--% | 48.6x | 7.31x | 4.95x | 32.02x | 37.01x | 36.38B | |
| 0.42% | 0.46% | 27.45x | 2.23x | 7.94x | 19.96x | 23.78x | 28.45B | |
| -.--% | -.--% | 33.26x | 23.86x | 5.44x | 24.73x | 25.88x | 16.33B | |
| -.--% | -.--% | 25.19x | 1.41x | 1.99x | 12.05x | 13.69x | 13.65B | |
| 1.16% | 1.32% | 22.83x | 2.56x | 2x | 8.66x | 13.3x | 13.56B | |
| -.--% | -.--% | 38.3x | 3.43x | 3.41x | 13.25x | 16.17x | 11.31B | |
| 0.44% | 0.44% | 61.83x | 5.17x | 9.23x | 26.23x | 28.67x | 11.22B | |
| -.--% | -.--% | -30.57x | 9x | 110x | -31.31x | -54.49x | 10.63B | |
| -.--% | -.--% | -31.09x | 8.99x | 1000.57x | -26.53x | -25.99x | 10.08B | |
| 0.65% | 0.78% | 34.69x | 3.86x | 4.08x | 17.18x | 26.62x | 9.18B | |
| -.--% | -.--% | -15.03x | 104.05x | 9.19x | -14.95x | -14.45x | 8.93B | |
| -.--% | -.--% | 31.31x | - | 15.06x | 27.92x | 28.08x | 8.55B | |
| -.--% | 0.45% | 19.46x | 2.28x | 4.33x | 11.39x | 14.83x | 8.65B | |
| -.--% | -.--% | -29.98x | 7.69x | 85.65x | -19.43x | -18.79x | 8.66B | |
| -.--% | -.--% | -94.88x | 4.25x | 4.85x | 24.41x | 259.21x | 8.11B | |
| Average | 0.2% | 0.25% | 9.53x | 12.41x | 89.74x | 6.83x | 20.73x | 17.47B | |
| Weighted average by Cap. | 0.26% | 0.3% | 17.80x | 10.15x | 79.59x | 9.90x | 18.62x |
- Stock Market
- Stocks
- CRDL Stock
- Sector Cardiol Therapeutics Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
